#ASH23 posters. CAR-T therapy comes with a 4⃣week monitoring for CRS/ICANS. is a flexible monitoring period possible? Why is that important to evaluate? 'cuz relocating has ⬆️ financial/physical burden on pts, ⬆️ #disparities #access #CART #lymsm

Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias pubmed.ncbi.nlm.nih.gov/38044594/ by William Wesson Nausheen Ahmed MD Leyla Shune MD Hamza Hashmi James Davis, PharmD, BCOP #Cart #USMIRC USMIRC News #MedTwitter #MedEd OncoAlert #mmsm KU Cancer Center

The Glass Wall: Gendered authorship disparities in CD 19 and BCMA CAR-T Clinical Trials for lymphoma and myeloma Out there by upcoming superstar aroog khaliq, md mentored by #USMIRC academy director Nausheen Ahmed MD and Muhammad Umair Mushtaq (Abu Mikael) Leyla Shune MD Mehdi Hamadani, MD Joaquina Baranda #mmsm

Thrilled that KU's work on CAR T safety and monitoring is gaining traction! Balancing Cures and Complications With CAR T-Cell Therapy targetedonc.com/view/balancing… via Targeted Oncology Nausheen Ahmed MD Al-Ola A Abdallah MD (USMIRC) Dr. Aliya Rashid IMChiefs